Addressing Barriers and Challenges to HCV Elimination
Knowledge, attitudes, and practices related to hepatitis C among gay and bisexual men in the era of direct-acting antivirals: implications for treatment and prevention.
Brener L, et al. J Cult Health Sex. 2020;22(5):551-567.
Falade-Nwulia O, et al. Int J Drug Policy. 2020;78:102714.
“Everybody living with a chronic disease is entitled to be cured”: challenges and opportunities in scaling up access to direct-acting antiviral hepatitis C virus treatment among people who inject drugs.
Goodyear T, et al. Int J Drug Policy. 2020;81:102766.
Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: a meta-analysis.
Hajarizadeh B, et al. J Hepatol. 2020;72(4):643-657.
Kushner T, Terrault NA. Hepatol Commun. 2019;3(1):20-28.
Barriers and facilitators to engaging in hepatitis C management and DAA therapy among general practitioners and drug and alcohol specialists—the practitioner experience.
Marshall AD, et al. Drug Alcohol Depend. 2020;206:107705.
Clients' perceptions of barriers and facilitators to implementing hepatitis C virus care in homeless shelters.
Masson CL, et al. BMC Infect Dis. 2020;20(1):386.
Bringing Local Communities Together to Eliminate Coinfection Through Knowledge and Partnerships
|Faculty:||David L. Wyles, MD; Stacey Trooskin, MD, PhD, MPH|